$CLVS pat does not release any info to boost share price - he only releases clinical product related info that is confirmed - he can’t take the risk because of his past with sec- and no anaylsts like him or they are loyal to larger pharma - so this is easy to manipulate until there is solid deal news which takes a lot of zoom calls - long wasted game
  • 2